As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, ...

The president posted talking points provided by one firm that donated millions, and his administration delayed a change on ...

The new model incorporates artificial intelligence to help make decisions and is being tested in six states beginning in ...

New York Gov. Kathy Hochul (D) holds a 14-point lead over Rep. Elise Stefanik (R-N.Y.) in a new poll from Siena, down from ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a ...

The Trump administration is set to announce a proposed rule that would cut off Medicare and Medicaid funds to hospitals that ...

The president has crowed about the billions of dollars collected so far from tariffs. That money could be at risk if the ...

President Trump has pushed to make the federal government more efficient, but changes to tax law could lead to deeper Social ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The "One Big Beautiful Bill" will cut $1 trillion from health-related programs like Medicaid, Medicare, and the ACA over the ...

Kennedy’s approach to health care as a matter of politics instead of science is a perfect fit in the Trump administration.

Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do in Europe and other peer countries, the so-called “Most Favored Nation” ...